Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Potential cost to patient safety as New Zealand debates access to medicinal cannabis
+Print Archive
Practice
Potential cost to patient safety as New Zealand debates access to medicinal cannabis
Wednesday 28 August 2019, 02:30 AM

The New Zealand Government is introducing a scheme for regulating medicinal cannabis
CLINICAL COMMENT
Michelle Glass and John Ashton from the University of Otago discuss whether untested cannabis-based products should enter the New Zealand healthcare system, as proposed by the Government’s recent consultation document
Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any pr
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.